Hematology and Oncology
Home Hematology and Oncology
Dasatinib + Blinatumomab Active for Ph-Positive ALL in Adults
Complete remission, overall survival seen in 98, 95 percent of patients in phase 2 study
Taking Lipid-Lowering Meds Tied to Lower Risk for Cancer Death
Adherence inversely linked to mortality related to breast cancer, CRC, melanoma in women
Interval Breast Cancers Tied to Worse Outcomes
Risk for breast cancer death more than threefold higher for interval versus screen-detected cancer
Insurance Tied to Odds of Cancer Surgery at High-Volume Centers
Uninsured, Medicare-, Medicaid-insured less likely to receive surgical cancer care at high-volume hospital
Rate of Injuries Increased Around Diagnosis of Cervical Cancer
Rates of iatrogenic, noniatrogenic injuries higher for women having diagnostic workup for cervical cancer
CDC: One-Year Survival 96.1 Percent for Male Breast Cancer
Relative survival varies by stage at diagnosis, from 98.7 to 25.9 percent for localized and distant stage, respectively
More Physical Activity, Less Sitting Beneficial for Seniors
Global mental, physical health improved with more MPVA, less sitting for seniors with, without cancer history
Linked Color Imaging Detects More Neoplastic Upper GI Lesions
More neoplastic lesions initially diagnosed in the examination group undergoing LCI first
Electronic Cigarettes Improve Long-Term Smoking Cessation
Quit rates higher in people randomly assigned to nicotine e-cigarettes versus nicotine replacement therapy
Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer
Risk higher in first five years of follow-up for those treated with breast-conserving surgery alone
